Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven W Martin

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Analytical Chemistry|July 24, 2012
Clinical pharmacokinetic assessment of an anti-MAdCAM monoclonal antibody therapeutic by LC-MS/MSMireia Fernández Ocaña, Ian T James, Musarat Kabir, et al.
British Journal of Clinical Pharmacology|January 30, 2018
Exposure-response characterization of tofacitinib efficacy in moderate to severe ulcerative colitis: Results from a dose-ranging phase 2 trialArnab Mukherjee, Anasuya Hazra, Mike K Smith, et al.
Pharmaceutical Research|September 2, 2003
Pharmacokinetic model to describe the lymphatic absorption of r-metHu-leptin after subcutaneous injection to sheepDanielle N McLennan, Christopher J H Porter, Glenn A Edwards, et al.
Clinical Pharmacology in Drug Development|January 29, 2021
Population Pharmacokinetics of Tofacitinib in Patients With Moderate to Severe Ulcerative ColitisCamille Vong, Steven W Martin, Chenhui Deng, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 8, 2004
Lymphatic absorption is the primary contributor to the systemic availability of epoetin Alfa following subcutaneous administration to sheepDanielle N McLennan, Christopher J H Porter, Glenn A Edwards, et al.
Pharmaceutical Research|September 5, 2006
The absorption of darbepoetin alfa occurs predominantly via the lymphatics following subcutaneous administration to sheepDanielle N McLennan, Christopher J H Porter, Glenn A Edwards, et al.
International Journal of Toxicology|October 14, 2003
A toxicity profile of osteoprotegerin in the cynomolgus monkeyBrenda B Smith, Mary Ellen Cosenza, Audrey Mancini, et al.
Journal of Theoretical Biology|December 5, 2012
A mathematical model of the human menstrual cycle for the administration of GnRH analoguesSusanna Röblitz, Claudia Stötzel, Peter Deuflhard, et al.
Advanced Drug Delivery Reviews|September 23, 2003
Design of PEGylated soluble tumor necrosis factor receptor type I (PEG sTNF-RI) for chronic inflammatory diseasesCarl K Edwards, Steven W Martin, James Seely, et al.
The AAPS Journal|December 3, 2014
Quantitative prediction of human pharmacokinetics for mAbs exhibiting target-mediated dispositionAman P Singh, Wojciech Krzyzanski, Steven W Martin, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Analytical Chemistry|July 24, 2012
Clinical pharmacokinetic assessment of an anti-MAdCAM monoclonal antibody therapeutic by LC-MS/MSMireia Fernández Ocaña, Ian T James, Musarat Kabir, et al.
British Journal of Clinical Pharmacology|January 30, 2018
Exposure-response characterization of tofacitinib efficacy in moderate to severe ulcerative colitis: Results from a dose-ranging phase 2 trialArnab Mukherjee, Anasuya Hazra, Mike K Smith, et al.
Pharmaceutical Research|September 2, 2003
Pharmacokinetic model to describe the lymphatic absorption of r-metHu-leptin after subcutaneous injection to sheepDanielle N McLennan, Christopher J H Porter, Glenn A Edwards, et al.
Clinical Pharmacology in Drug Development|January 29, 2021
Population Pharmacokinetics of Tofacitinib in Patients With Moderate to Severe Ulcerative ColitisCamille Vong, Steven W Martin, Chenhui Deng, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 8, 2004
Lymphatic absorption is the primary contributor to the systemic availability of epoetin Alfa following subcutaneous administration to sheepDanielle N McLennan, Christopher J H Porter, Glenn A Edwards, et al.
Pharmaceutical Research|September 5, 2006
The absorption of darbepoetin alfa occurs predominantly via the lymphatics following subcutaneous administration to sheepDanielle N McLennan, Christopher J H Porter, Glenn A Edwards, et al.
International Journal of Toxicology|October 14, 2003
A toxicity profile of osteoprotegerin in the cynomolgus monkeyBrenda B Smith, Mary Ellen Cosenza, Audrey Mancini, et al.
Journal of Theoretical Biology|December 5, 2012
A mathematical model of the human menstrual cycle for the administration of GnRH analoguesSusanna Röblitz, Claudia Stötzel, Peter Deuflhard, et al.
Advanced Drug Delivery Reviews|September 23, 2003
Design of PEGylated soluble tumor necrosis factor receptor type I (PEG sTNF-RI) for chronic inflammatory diseasesCarl K Edwards, Steven W Martin, James Seely, et al.
The AAPS Journal|December 3, 2014
Quantitative prediction of human pharmacokinetics for mAbs exhibiting target-mediated dispositionAman P Singh, Wojciech Krzyzanski, Steven W Martin, et al.
Pageof 3